Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Reich N, Hlscher C (2024) Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimers and Parkinsons disease
Imagine navigating your busy day in Atlanta without being consumed by thoughts of your next meal
Their undesirable qualities include side effects such as nausea and muscle loss
doi: 10.1089/jmf.2006.9.33 41 YuJKimAK
Discussion Due to the central roles exerted by the three metabolically related peptide hormone receptors (GIPR, GLP-1R and GCGR) in the management of T2DM and obesity, the concept of combinatorial agonism or polypharmacology to synergize metabolic actions and maximize therapeutic benefits has been explored in the past decade with remarkable preclinical and clinical achievements
US$ 23.91
US$ 28.97
US$ 26.83
US$ 22.20
